Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. Pursuant to Sections 2.4(b) and 2.5(b) of the Amended and Restated Bylaws of Atea Pharmaceuticals, Inc. (the “Company”), which were filed as Exhib
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release of Atea Pharmaceuticals, Inc., dated March 21, 2025 104 Cover Page Interactive Dat